Hypothyroidism medical therapy: Difference between revisions
No edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Hypothyroidism}} | {{Hypothyroidism}} | ||
{{CMG}} | {{CMG}} | ||
| Line 17: | Line 18: | ||
====Subclinical hypothyroidism==== | ====Subclinical hypothyroidism==== | ||
A [[meta-analysis]] by the [[Cochrane Collaboration]] found no benefit except "some parameters of lipid profiles and left ventricular function".<ref name="pmid17636722">{{cite journal |author=Villar H, Saconato H, Valente O, Atallah A |title=Thyroid hormone replacement for subclinical hypothyroidism |journal=Cochrane database of systematic reviews (Online) |volume= |issue=3 |pages=CD003419 |year=2007 |pmid=17636722 |doi=10.1002/14651858.CD003419.pub2}}</ref> | A [[meta-analysis]] by the [[Cochrane Collaboration]] found no benefit except "some parameters of lipid profiles and left ventricular function".<ref name="pmid17636722">{{cite journal |author=Villar H, Saconato H, Valente O, Atallah A |title=Thyroid hormone replacement for subclinical hypothyroidism |journal=Cochrane database of systematic reviews (Online) |volume= |issue=3 |pages=CD003419 |year=2007 |pmid=17636722 |doi=10.1002/14651858.CD003419.pub2}}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Endocrinology]] | |||
{{WS}} | |||
{{WH}} | |||
Revision as of 19:50, 27 June 2016
|
Hypothyroidism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Pharmacotherapy
Both synthetic and animal-derived thyroid tablets are available and can be prescribed for patients in need of additional thyroid hormone. Thyroid hormone is taken daily, and doctors can monitor blood levels to help assure proper dosaging.
The American Thyroid Association cautions against taking herbal remedies, and warns that taking too much iodine can actually worsen hypothyroidism.[1]
Some researchers would suggest that there is no benefit to treatment with the T4 - T3 combination therapy over the T4 monotherapy. A meta-analysis of 11 randomized controlled trials found no advantage with the T4 - T3 combination therapy over the T4 monotherapy.
However, many of the studies involved in this meta-analysis were not properly designed. They tested the medication's effectiveness by providing the same dose of thyroid medication to each patient and by utilizing the TSH test as a measure of treatment effectiveness. Thyroid medication must be individualized to the patient, carefully observing free T4 and free T3 (not TSH, which is a diagnostic tool but not a treatment tool). Beneficial effects would not expect to be seen at doses not tailored to the individual's needs. Clinically, most physicians prescribing T3 as part or all of a hypothyroid patient's treatment find that most patients receiving T3 in fact must be on a larger dose than was administered in these studies. The meta-analysis results ought to be held in question, therefore; and the knowledgeable physician will administer T3 medication for the hypothyroid patient who continues to present with symptoms and whose free T3 level is low, or low in the range.
Subclinical hypothyroidism
A meta-analysis by the Cochrane Collaboration found no benefit except "some parameters of lipid profiles and left ventricular function".[2]